NITROXIDE MODIFIED NON-STEROIDAL ANTI-INFLAMMATORY COMPOUNDS AND USES THEREOF IN THE TREATMENT AND PREVENTION OF DISEASES OR DISORDERS
申请人:Wink David A.
公开号:US20120263650A1
公开(公告)日:2012-10-18
Disclosed are nitroxide modified NSAID compounds of the formula (I) or a pharmaceutically acceptable salt or enantiomer thereof:
in which R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, R
7
, R
8
, R
9
, R
10
, R
11
, and n are defined herein and pharmaceutical compositions thereof. Further disclosed is a method of treating or preventing various disorders, such as inflammation, cancer, diabetes, a cardiovascular disorder, weight gain, polyps, and/or chronic pain, in a patient comprising administering an effective amount of a compound or pharmaceutically acceptable salt or enantiomer of formula (I). A method of imaging the compound or pharmaceutically acceptable salt or enantiomer of formula (I) in the body of the animal is also provided.
揭示了具有以下结构式(I)的硝基氧自由基修饰的NSAID化合物或其药用盐或对映体:其中R1、R2、R3、R4、R5、R6、R7、R8、R9、R10、R11和n在此处被定义,并其药物组合物。进一步揭示了一种治疗或预防各种疾病的方法,如炎症、癌症、糖尿病、心血管疾病、体重增加、息肉和/或慢性疼痛,在患者中包括给予化合物或结构式(I)的药用盐或对映体的有效量。还提供了一种在动物体内成像化合物或结构式(I)的药用盐或对映体的方法。